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Abstract
Background: Human immunodeficiency virus infected individuals are prone to malnutrition due
to increased energy requirements, enteropathy and increased catabolism. Trace elements such as
zinc and selenium have major role in maintaining a healthy immune system. This study was designed
to evaluate the nutritional status of Iranian subjects who were newly diagnosed with human
immunodeficiency virus infection and to compare serum level of zinc and selenium in these patients
with those of the sex and aged match healthy subjects.
Methods: After an interview and physical examination, nutritional assessment was done based on
clinical and anthropometric parameters. Body mass index (normal range 18.5–27 kg/m2 based on
age) of less than 16, 16–16.9 and 17–18.4 kg/m2 were considered as severe, moderate and mild
malnutrition respectively. Serum level of zinc and selenium were measured by graphite furnace
atomic absorption.
Results: Severe, moderate and mild malnutrition were detected in 15%, 38% and 24% of human
immunodeficiency virus infected individuals respectively. Compared with the healthy control group,
serum level of zinc and selenium in the human immunodeficiency virus infected subjects were
significantly lower (P = 0.01 and P = 0.02 respectively).
Conclusion: Malnutrition found to be prevalent in Iranian human immunodeficiency virus infected
individuals and low serum zinc and selenium levels are common in this population.
Background
Human Immunodeficiency Virus (HIV) infection is a
major health problem in the world and HIV infected indi-
viduals are vulnerable to malnutrition due to several fac-
tors including inadequate nutrient intake (anorexia,
gastrointestinal complications such as nausea and vomit-
ing, oral and esophageal sores), nutrient loss (malabsorp-
tion and/or diarrhea), metabolic alteration (increased
protein turn over and changes in fatty acid metabolism),
and drug-nutrient interactions [1,2].
Although malnutrition is more frequent at the end of HIV
infection course, it can also occur at the onset of the dis-
ease, before sever immunosuppression [3].
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Malnutrition and HIV infection can deteriorate immune
system function including decline in CD4 lymphocyte
count and delayed type immune reactions [2].
Functional status and survival of HIV-infected patients are
affected by their nutritional conditions [4]. The critical
role of nutritional support and highly active anti-retrovi-
ral therapy (HAART) in HIV-infected individuals has been
approved. American Dietetic Association recommends
nutritional support as a part of the care provided to HIV-
infected patients [5].
Trace elements especially zinc (Zn) and selenium (Se) are
important for maintaining a healthy immune system.
Zinc deficiency can declines T cells generation and
depresses humoral and cell-mediated immunity [6,7].
Selenium deficiency also has several medical implications
including impaired immune response [8]. Taylor et al pro-
posed a role for Se modification both in-vitro and in-vivo
in HIV infection [9]. The main route of HIV transmission
in IRAN is via injection drug use (IDU) and there is no
data about nutritional status among this population. The
goals of this study were 1) to evaluate nutritional status of
newly diagnosed Iranian HIV-infected individuals and 2)
to compare the serum Zn and Se levels in these patients
with those of healthy individuals.
Method
This study is a one-year cross-sectional, descriptive ana-
lytic survey conducted at Iranian Referral HIV/AIDS
Research Center affiliated to Tehran University of Medical
Sciences. This center is supported by Iranian Ministry of
Health and Medical Education and provides free services
such as Para-clinical, clinical and consultation for each
volunteer who may be at risk of infection by HIV or any
other sexually transmitted disease. The study group
included newly diagnosed HIV infected adult males
whose infection was confirmed with the anti-HIV anti-
body tests (ELISA and Western-blot). The control subjects
were age matched healthy males related to HIV infected
individuals (who accompanied HIV infected patients),
without any medical problem at the time of the study or
history of any chronic disease and with negative anti-HIV
antibody test.
The study protocol was approved by the institutional
review board and all patients provided written consent
form.
During patient's interview, demographic data including
social, behavioral and medical history were collected in
the designed forms. Nutritional status of each patient was
assessed using anthropometric parameters. Body weight
was determined to the nearest 0.1 kilogram (kg) using
adult balance and standing height was determined to the
nearest one centimeter (Cm). Body Mass Index (BMI) was
calculated using the following formula: BMI = Body
Weight (kg) divided by [Height (m)]2. BMI (normal range
18.5–27 kg/m2based on age) of less than 16, 16–16.9 and
17–18.4 kg/m2 were considered as severe, moderate and
mild malnutrition respectively [10]. All patients were
asked about body weight changes during past six months.
Up to 10% body weight loss was considered significant
and more than 10% body weight loss was considered
severe weight loss [11]. According to definition of Center
of Disease Control and Prevention (CDC), wasting syn-
drome was defined as an involuntary weight loss of
greater than 10% of baseline body weight during the past
12 months or at least 5% loss of body weight during the
past six months [12].
Clinical assessments including medical history and phys-
ical examination were conducted to identify any sign or
cause of malnutrition. Physical appearance, opportunistic
infections, diarrhea, symptoms of gastrointestinal distress
such as nausea and vomiting, medications, use of herbal
supplements and functional status were considered in the
clinical assessment. Hepatitis B surface antigen (HBsAg)
was detected by second generation enzyme linked immu-
noassay kit (ELISA), Diasorin Italy and third generation
ELISA kit, DRG, Germany was used for HCV-Ab detection.
Six milliliters (mL) of fasting blood sample was collected
from all HIV-infected and healthy subjects under trace ele-
ments free condition. Blood samples were centrifuged at
3000 g for five minutes. The collected serum was stored at
-70°C until analysis. All glassware and bottles used for
separation of serum and further analysis were previously
soaked in 10% nitric acid and rinsed thoroughly with de-
ionized water. Serum Zn and Se levels were measured
using atomic absorption spectrophotometer (Atomic
absorption spectrophotometer Shimadzu, AA-680,
Japan). Samples and standards concentrations were read
in duplicate.
For this study, Zn deficiency was defined as a serum level
< 67 mcg/dL, using the cut-off referenced by Bender and
Bender for normal plasma Zn (67–183 mcg/dL) [13].
Selenium deficiency was defined as a level < 85 mcg/L,
which is a cut-off associated with increased mortality [14].
Data was analyzed using SPSS (Chicago, IL, USA) soft-
ware, version 11.5. Normal distribution of data were
assessed using Kolmogorov-Smirnov test and independ-
ent sample t-test was used to compare numeric variables
such as age, weight, high, serum albumin, serum Zn and
Se levels between HIV-infected patients and healthy sub-
jects. Differences between serum Zn and Se concentra-
tions from recommended cutoffs were evaluated by one-
sample t-test. ANOVA was used to compare serum Zn andBMC Infectious Diseases 2008, 8:165 http://www.biomedcentral.com/1471-2334/8/165
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Se concentrations between groups that were categorized
based on malnutrition severity. For determination of dif-
ferences between severity and prevalence of malnutrition
between HIV infected individuals and healthy group, chi-
square and fisher-exact test were used. Correlations
between data were evaluated using pearson correlation.
Descriptive statistics (cross-tabs) followed by selection of
chi-square and risk were used for generation of odds ratio
and confidence interval. P-values of less than 0.05 were
considered as significant.
Results
One hundred HIV-infected adult patients with the mean
age of 35.4 ± 7.8 years (range: 21–45 years old) and 100
healthy individuals with the mean age of 32.4 ± 7.8 years
(range of 20–43 years old) completed this study. Table 1
shows socioeconomic status and past medical history of
HIV-infected patients. Comparisons of demographic char-
acteristics (including age, weight, height, BMI) and some
nutritional parameters (including serum albumin concen-
tration, and CD4 lymphocytes count) of HIV-infected and
healthy subjects are shown in table 2. None of the HIV-
infected individuals express any significant past medical
problem. In this study 31% of injection drug users had a
history of medication consumption such as benzodi-
azepines, acetaminophen-codeine, tramadol, antibiotics
and non-steroidal anti-inflammatory drugs and 3% of
them used herbal medications. None of the HIV-infected
Table 1: Demographic data including socioeconomic status of HIV infected individuals
Parameters Number of patient (Percent)
Route of HIV infection
IDU* 63 (63)
IDU and sexual contact 9 (9)
Sexual 20 (20)
Unknown 8 (8)
Mean period of intravenous injection 2.1 ± 1.6 years
Positive prison history 29(29)
Substances injected (in IDU group)
Heroine 64 (89)
Others (cocaine, buprenorphine, benzodiazepines, barbiturates) 8 (11)
Smoking 61 (61)
Alcohol 7 (7)
Marital status
Married 47 (47)
Unmarried 53 (53)
Employment condition
Employed 37 (37)
Unemployed 63 (63)
Mean monthly Income 500000 Rials (50 $)
Education
0–10 years 83 (83)
> 10 years 17 (17)
Homeless 21 (21)
With family 79 (79)
HBs-Ag positive 11 (11)
Anti-HCV Ab positive 38 (38)
*IDU: Injection Drug UseBMC Infectious Diseases 2008, 8:165 http://www.biomedcentral.com/1471-2334/8/165
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patients had a history of vitamin or mineral supplemen-
tary consumption.
Most of the HIV infected individuals were pale, 60% of
them were anemic (serum hemoglobin level of less than
12 g/dL) and all of them had some degree of temporal
atrophy. Gastrointestinal symptoms including nauseas,
vomiting, diarrhea and decreased appetite were observed
in 9% of patients.
Significant and severe recent weight losses were detected
in 7% and 5% of patients respectively. Based on CDC def-
inition, 12% of the patients had wasting syndrome.
Serum albumin level was significantly lower in HIV-
infected patients compared with healthy subjects (P =
0.03). Seventeen percent of patients had serum albumin
level of less than 2.5 g/dL. Additionally, serum albumin
concentration was significantly lower in HIV-infected sub-
jects who suffered wasting syndrome than the HIV-posi-
tive individuals without wasting (2.1 g/dL versus 2.7 g/dL;
P = 0.01). There was positive correlation between patients'
serum albumin level and CD4 lymphocyte count (r = 0.9,
P = 0.003). Additionally individuals with severe malnutri-
tion had a significant lower CD4 counts in comparison
with individuals with normal, mild, or moderate malnu-
trition. (P = 0.004).
Table 3 compares the prevalence of different types of mal-
nutrition between HIV-infected individuals and healthy
subjects. Moderate malnutrition was the most prevalent
type of malnutrition in HIV-infected individuals
(observed in 38% of patients) followed by mild malnutri-
tion (observed in 24% of the patients).
Serum level of Zn and Se among HIV-infected and healthy
subjects are shown in table 4. As can be seen serum level
of Zn and Se were significantly lower in HIV-infected
patients (P = 0.01, P = 0.02 respectively). Mean concentra-
tions of Zn and Se were significantly lower than recom-
mended cutoffs (p = 0.01 and p = 0.03 respectively). In
addition those patients who may have been infected by
used syringe had significant lower serum Zn (32.4 ± 10.6
vs. 67.2 ± 14.3 mcg/dL) and Se (55.8 ± 14.6 vs. 84.1 ± 9.9
mcg/L) concentrations compared with those who were
probably infected via sexual contact (P < 0.001 for both
comparisons).
Prevalence of Zn and Se deficiency of the HIV infected
individuals and healthy persons also are shown in Table
4. As presented in this Table, 65% and 38% of HIV
infected individuals had Zn and Se deficiency respectively.
Table 5 compares serum Zn and Se levels in patients with
various severity of malnutrition.
Patients with moderate malnutrition had significant
lower serum Zn and Se levels than non-depleted patients.
Severe malnutrition was a risk factor for Zn deficiency
Table 2: The study groups baseline characteristics
Parameters HIV infected Patients Healthy group P-value
Number of subjects 100 100 -
Age (year) (mean ± SD) 35.4 ± 7.8 32.4 ± 7.8 0.21
Weight (Kg) (mean ± SD) 51.0 ± 8.4 72.2 ± 12.9 0.04
Height (Cm) (mean ± SD) 169.9 ± 10.1 171.0 ± 9.1 0.43
BMI1 (kg/m2) (mean ± SD) 17.3 ± 2.3 24.2 ± 3.0 0.03
IBW2 (kg) (mean ± SD) 68.3 ± 7.2 71.0 ± 10.2 0.54
Serum Albumin (g/dL) (mean ± SD) 2.6 ± 1.4 3.6 ± 1.7 0.03
CD4 (Cell/mm3) (mean ± SD) 253 ± 50 1120 ± 210 0.01
1-Body Mass Index.
2-Ideal Body Weight
Table 3: Nutritional status* of the study populations
Category HIV infected group (percent) Healthy group (percent) P value
Mild malnutrition 24 (24) 15 (15) 0.01
Moderate malnutrition 38 (38) 0 < 0.001
Severe malnutrition 15 (15) 0 < 0.001
Normal 23 (23) 85 (85) 0.006
* Nutritional status was calculated based on individual's BMI. BMI (normal range 18.5–27 kg/m2 based on age) of less than 16, 16–16.9 and 17–18.4 
kg/m2 were considered as severe, moderate and mild malnutrition respectively.BMC Infectious Diseases 2008, 8:165 http://www.biomedcentral.com/1471-2334/8/165
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(Odds Ratio = 2.3 (95% confidence interval = 1.2–4.5 and
P = 0.001).
Discussion and conclusion
In this study 77% of newly diagnosed HIV-infected
patients who were not in advanced phase of the disease
were evaluated and founded to have some degree of mal-
nutrition.
Malnutrition is a significant clinical problem in HIV-
infected individuals. In this population, wasting has been
associated with disease progression and increased mortal-
ity [15].
Although malnutrition is usually encountered at the
advanced phase or end of the HIV-infection course, how-
ever, as seen in our study it may also occur in the first
stages of the HIV-infection as well [16].
According to the last report of Iranian Diseases Prevention
and Control Center, 94.3% of Iranian HIV infected indi-
viduals are male [17] and consequently most referred
patients to our center were male, so the present study was
designed for this sex group.
As anthropometric measurements provide inexpensive
and non invasive method to evaluate nutritional status
[18], these parameters were used in this study to evaluate
nutritional status of HIV-infected individuals.
The results of this study showed moderate to severe mal-
nutrition in 53% of the HIV-infected subjects. Contrary to
other studies which stated sexual contact as the main
route of HIV infection [19,20], the most prevalent route of
HIV infection in our patients was IDU. Moderate to severe
malnutrition were detected in 68% of this main sub-
group of the patents that is comparable with the findings
of Nazrul Islam et al who reported mild to severe malnu-
trition in more than 60% of their patients who were drug
addicts [21]. Due to educational, socioeconomic and
behavioral characteristics, addicted persons especially
injection drug users are more vulnerable to malnutrition
[21]. Most of the injection drug users in present study had
less than 10 years education and were unemployed,
unmarried and smoker with an insufficient monthly
income. Also some of them were homeless and alcoholic.
Although it was reported that there is not correlation
between body weight loss and level of immunosuppres-
sion [16], the results of this study showed significant
reverse relationship between severity of weight loss and
serum CD4 lymphocyte count that is compatible with the
findings of Rivera et al [22].
As reported in another study [23], wasting syndrome was
present in about 12% of the patients. During wasting in
HIV infection, the body tries to compensate energy from
available sources such as visceral proteins [24]. Although
normal serum albumin concentration has been reported
in HIV-infected patients [5], serum albumin levels in our
patients were significantly lower than those of the healthy
subjects. Also the patients with wasting syndrome had sig-
nificant lower serum albumin than the patients without
wasting.
Similar to the findings of Koch et al [25], Graham et al
[26] and Zamrzly et al [27], serum levels of Zn and Se in
our HIV-infected individuals were significantly lower than
the healthy group.
This is the first study about nutritional status of Iranian
HIV infected individuals and there are some limitations to
our study. The first one is that the cross sectional design of
the study limits our conclusions and does not provide
information about effects of nutritional status on disease
progression and outcome of HIV infected individuals. We
have started a controlled clinical trial to assess effects of
nutritional support on disease progression and outcome
Table 4: Mean ± SD of serum Zn and Se concentrations and prevalence of deficiency in HIV infected and healthy individuals
Parameter HIV infected group Healthy group P value
Zn concentration (mcg/dl) 51.7 ± 14.2 82.9 ± 14.8 0.01
Se concentration (mcg/l) 66.4 ± 11.2 91.7 ± 11.9 0.02
Number of individuals with Zn deficiency (percent) 65 (65) 8(8) < 0.001
Number of individuals with Se deficiency (percent) 38 (38) 2 (2) < 0.001
Table 5: Serum Zn and Se concentrations in HIV infected 
individuals based on severity of malnutrition*
Group Zn (mcg/dL) Se (mcg/L)
Mild malnutrition 66.4 ± 10.7 85.9 ± 12.4
Moderate malnutrition 40.2 ± 11.0 58.3 ± 10.3
Severe malnutrition 33.3 ± 9.6 50.4 ± 13.2
Normal 77.2 ± 16.2 89.5 ± 11.6
P value 0.03 0.04
* Severity of malnutrition was determined based on individual's BMI. 
BMI (normal range 18.5–27 kg/m2 based on age) of less than 16, 16–
16.9 and 17–18.4 kg/m2 were considered as severe, moderate and 
mild malnutrition respectively.BMC Infectious Diseases 2008, 8:165 http://www.biomedcentral.com/1471-2334/8/165
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of HIV infected patients. In another hand we know that
serum Zn and Se levels may not be the best indicator of
total stores for these trace elements in the body and cellu-
lar concentrations or related enzymes activity may be
more reliable.
Based on World Health Organization nutritional recom-
mendations for HIV infected persons, adequate nutrition
is critical for health and survival for all subjects regardless
of HIV infection condition [28]. Following presentation
of the study results, nutritional assessment is a part of clin-
ical assessment of HIV infected individuals. Patients and
their family have counselling about maintain adequate
healthy diet and nutrition care in our centre. Also it is
emphasized that these patients should be taking daily rec-
ommended of relevant micronutrients through diet or
supplements.
In conclusion malnutrition and serum Zn and Se defi-
ciency are common in Iranian HIV-infected patients and
early evaluation of nutritional status of these subjects and
providing appropriate nutritional support and mineral
supplementation along with the specific anti-retroviral
treatment are recommended.
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